Literature DB >> 26992945

APRIL levels are associated with disease activity in human chronic graft-versus-host disease.

François Chasset1, Adèle de Masson1, Hélène Le Buanec2, Aliénor Xhaard3, Flore Sicre de Fontbrune3, Marie Robin3, Michel Rybojad4, Nathalie Parquet5, Anne C Brignier5, Tereza Coman3, Djaouida Bengoufa6, Anne Bergeron7, Régis Peffault de Latour3, Martine Bagot1, Armand Bensussan2, Gérard Socié8, Jean-David Bouaziz1.   

Abstract

Entities:  

Keywords:  APRIL; B cell homeostasis; BAFF; autoantibody; chronic graft-versus-host disease

Mesh：

Substances：

Year:  2016        PMID： 26992945      PMCID： PMC5004480          DOI： 10.3324/haematol.2016.145409

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Peripheral development of B cells in mouse and man.

Authors:  Rita Carsetti; M Manuela Rosado; Hedda Wardmann
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

Review 3.  B cells in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Bruce R Blazar; Corey Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-12       Impact factor: 5.742

4.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

5.  Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.

Authors:  Caron A Jacobson; Lixian Sun; Haesook T Kim; Sean M McDonough; Carol G Reynolds; Michael Schowalter; John Koreth; Corey S Cutler; Vincent T Ho; Edwin P Alyea; Philippe Armand; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Stefanie Sarantopoulos
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-23       Impact factor: 5.742

6.  Regulated expression of BAFF-binding receptors during human B cell differentiation.

Authors:  Jaime R Darce; Bonnie K Arendt; Xiaosheng Wu; Diane F Jelinek
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

7.  High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Nazmim S Bhuiya; Corey S Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

8.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey S Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

9.  Advances in human B cell phenotypic profiling.

Authors:  Denise A Kaminski; Chungwen Wei; Yu Qian; Alexander F Rosenberg; Ignacio Sanz
Journal:  Front Immunol       Date:  2012-10-10       Impact factor: 7.561

10.  Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.

Authors:  Anne Saussine; Abdellatif Tazi; Séverine Feuillet; Michel Rybojad; Caroline Juillard; Anne Bergeron; Valérie Dessirier; Fatiha Bouhidel; Anne Janin; Armand Bensussan; Martine Bagot; Jean-David Bouaziz
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240
View more
  4 in total

Review 1.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

2.  B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.

Authors:  R M Saliba; S Sarantopoulos; C L Kitko; A Pawarode; S C Goldstein; J Magenau; A M Alousi; T Churay; H Justman; S Paczesny; P Reddy; D R Couriel
Journal:  Bone Marrow Transplant       Date:  2017-05-08       Impact factor: 5.483

3.  Monitoring of Soluble Forms of BAFF System (BAFF, APRIL, sR-BAFF, sTACI and sBCMA) in Kidney Transplantation.

Authors:  Isabel Legaz; Manuel Muro; Rafael Alfaro; Santiago Llorente; Pedro Martinez; Víctor Jimenez-Coll; Helios Martínez-Banaclocha; José Antonio Galián; Carmen Botella; María Rosa Moya-Quiles; Jesús de la Peña-Moral; Alfredo Minguela
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-09-22       Impact factor: 3.831

4.  Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Authors:  Arwen Stikvoort; Yang Chen; Emelie Rådestad; Johan Törlén; Tadepally Lakshmikanth; Andreas Björklund; Jaromir Mikes; Adnane Achour; Jens Gertow; Berit Sundberg; Mats Remberger; Mikael Sundin; Jonas Mattsson; Petter Brodin; Michael Uhlin
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.